Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 4,965.00
-105.00 (-2.07%)
Dec 30, 2025, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 486.9 billion as of December 30, 2025. Its market cap has decreased by -14.01% in one year.
Market Cap
486.90B
Enterprise Value
457.55B
Revenue
1.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,965.00
Market Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 486.90B, an increase of 925.19%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 486.90B | -13.34% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.97T |
| Celltrion | 39.67T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.44T |
| HLB Co., Ltd. | 6.45T |
| LigaChem Biosciences | 6.36T |